T Scientific Co.,Ltd (KOSDAQ:A057680) announced a private placement of series 14 non-guaranteed private equity non-separable bond with underwriting rights for gross proceeds of KRW 10,000,000,000 on January 4, 2021. The transaction will include participation from Swanicoco Co., Ltd. for KRW 9,000,000,000, Jinwon Kang for KRW 500,000,000 and Seo Yoon-seong for KRW 500,000,000. The bonds will not bear any coupon rate, bear yield to maturity of 0% and will mature on January 12, 2024. The bonds are 100% convertible into 2,904,443 common shares at a conversion price of KRW 3,443 from January 12, 2022 to December 11, 2023. The shares have a hold period of one year. The company will raise funding through third party allotment. The transaction is expected to close on January 12, 2021. The transaction has been approved by the board of directors of the company.